|
- BioNTech
BioNTech guides you through the promising world of immunotherapies Find information on basic research and new developments of new treatment options
- BioNTech - Wikipedia
BioNTech SE ( biːˈɒntɛk bee-ON-tek; or baɪˈɒntɛk bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases
- BioNTech to wind down cell therapy manufacturing in Maryland
Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U S plant
- BioNTech US
BioNTech US is a fully integrated subsidiary with a strong foundation in Europe and a focus on the development of novel neoantigen-targeted T cell therapies, complementing BioNTech’s highly innovative scientific approach and diversified pipeline of transformative cancer medicines
- BioNTech Clinical Trials | Advancing Health Through Innovation
Discover how BioNTech is pioneering novel medicines for cancer and infectious diseases Learn more about our clinical trials, the importance of participation, and how to get involved in advancing global health
- BioNTech SE Company Profile - Overview - GlobalData
BioNTech SE (BioNTech) is a biotechnology company that develops immunotherapies for cancer and infectious diseases
- BioNTech SE to Release Second Quarter 2025 Financial Results . . . - Nasdaq
BioNTech will announce Q2 2025 financial results on August 4, followed by a conference call and webcast Quiver AI Summary BioNTech SE will release its financial results for the second quarter of
- BioNTech - Simple English Wikipedia, the free encyclopedia
BioNTech SE (ˈbaɪɒnˌtek) is a German biotechnology company dedicated to the creation of active immunotherapies for treatments of serious diseases BioNTech headquarters in An der Goldgrube street, Mainz
|
|
|